Shield Therapeutics plc (AIM:STX)

London · Delayed Price · Currency is GBP · Price in GBX

4.660

-0.236 (-4.82%)

Sep 11, 2026, 4:35 PM GMT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
ACCRUFeR®/FeRACCRU®	49.70M	32.18M	13.09M	5.50M	2.06M
Total	49.70M	32.18M	13.09M	5.50M	2.06M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	45.78M	29.27M	11.57M	3.53M	82.60K
The Netherlands	2.76M	2.14M	1.50M	1.78M	1.23M
Canada	831.00K	320.00K	-	185.00K	-
Japan	338.00K	322.00K	-	-	-
South Korea	-	122.00K	20.00K	6.00K	744.73K
Total	49.70M	32.18M	13.09M	5.49M	2.06M